Profound Medical (PROF) Liabilities and Shareholders Equity (2018 - 2026)

Profound Medical's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $73.5 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 20.69% year-over-year to $73.5 million; the TTM figure through Mar 2026 stood at $242.9 million (up 85.28% YoY), while the FY2025 annual figure was $77.5 million, up 10.31% from the prior year.
• Liabilities and Shareholders Equity was $73.5 million for Q1 2026 at Profound Medical, down from $77.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $77.5 million in Q4 2025 to a low of $42.3 million in Q3 2025.
• Historically, Liabilities and Shareholders Equity has averaged $60.3 million across 5 years, with a median of $62.6 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity plunged 31.77% in 2023, then soared 59.78% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $64.4 million in 2022, then slumped by 31.77% to $44.0 million in 2023, then jumped by 59.78% to $70.2 million in 2024, then climbed by 10.31% to $77.5 million in 2025, then fell by 5.19% to $73.5 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $73.5 million (Q1 2026), $77.5 million (Q4 2025), and $42.3 million (Q3 2025), per Business Quant data.